CD4 and neoplasm: Furthermore, to efficiently unleash immune effector cells, Tian et al. uncovered tumor vascular normalization synergism and ICIs (either anti-PD1 or anti-CTLA4 antibodies) to be operative and parallel CD4 T cell activation [65].